BioMr. LeBlanc joined Great Point Partners’ CMr. LeBlanc joined Great Point Partners’ CEO Advisory Board in 2012 and is currently on the Board of Softbox Systems, a GPP II portfolio company, and was previously a Board member of Cytovance Biologics, a GPP I portfolio company. Mr. LeBlanc is the current CEO of Caprion Proteomics, a company in which GPP invested in 2007 and sold in 2012 for 3.4 times invested capital a ....
Access "Martin LeBlanc" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any)
in one connected platform (AcquityData).
We use essential cookies to run this site (like keeping you signed in), and — only with your consent — analytics cookies to understand how the site is used. See our
Privacy Policy for details on what we collect and why.